Peptides · Peptide comparison
Thymosin Alpha-1 vs Thymulin (FTS)
Your immune system's master trainer—a naturally occurring thymus peptide that wakes up tired immune cells, helps your body fight infections, and keeps your defenses sharp as you age.
Zinc-dependent thymic hormone for immune restoration and T cell maturation
- Immune
- Immune
At a glance
Quick comparison
Efficacy
Benefit ratings
Immune Activation
Infection Fighting
Immune Balance
Immune Restoration
Anti-Inflammatory
Age-Related Immune Decline
Technical data
Compound specifications
Thymosin Alpha-1
- Molecular formula
- C129H215N33O55
- Molecular weight
- 3108.32 g/mol
- Half-life
- Approximately 2 hours
- Bioavailability
- High when injected subcutaneously (rapid absorption, peak at ~2 hours)
- CAS number
- 62304-98-7
Thymulin (FTS)
- Molecular formula
- C33H54N12O15
- Molecular weight
- 858.9 g/mol
- Half-life
- Approximately 2 hours
- Bioavailability
- Low oral bioavailability (injected administration required)
- CAS number
- 63958-90-7
Protocols
Dosing compared
Thymosin Alpha-1
Subcutaneous injection
- 1.6 mgTwice weekly (3-4 days apart) · 6-12 monthsEstablished clinical dose for thymalfasin (Zadaxin); body-surface-scaled as 900 mcg/m2 [4][6]. Phase III chronic hepatitis B trials used 1.6 mg SC twice weekly for 6-12 months [4].
- 1.6 mg daily, then 1.6 mg twice weeklyDaily for an initial loading period, then twice weekly · 12+ weeksThe schedule used in a randomized trial in HBV-related acute-on-chronic liver failure: 1.6 mg daily for the first week, then twice weekly to week 12 [3].
Thymulin (FTS)
Subcutaneous injection
- 1-2 mgOnce daily (often dosed in the evening) · 10-20 day courses, repeated cyclicallyResearch-practice dosing for immune support; thymulin requires injectable delivery due to low oral bioavailability and a zinc ion for activity, so zinc co-supplementation is commonly paired [1].
Intradermal injection
- 100-400 mcgThree times weekly · Several weeksLower microgram-range intradermal dosing is used in some research protocols as a conservative entry point [1].
Applications
Best suited for
Thymosin Alpha-1
- Chronic Hepatitis B or C Support
- Thymosin Alpha-1 has its strongest clinical evidence here. Multiple trials show it helps clear viral loads and normalize liver enzymes, especially when combined with antiviral medications. It's approved in over 30 countries specifically for hepatitis treatment.
- Cancer Treatment Support
- When used alongside chemotherapy, Thymosin Alpha-1 may help maintain immune function that chemo tends to suppress. Research in lung cancer, melanoma, and liver cancer shows improved outcomes when added to standard treatments. It helps your immune system keep fighting even during tough treatments.
- Age-Related Immune Decline
- As you age, your thymus shrinks and produces less thymosin naturally—a process called immunosenescence. Supplementing with Thymosin Alpha-1 may help compensate, keeping your immune defenses more youthful and responsive. Think of it as replacing what your body makes less of over time.
- Severe Infection Recovery
- In sepsis and critical infections, Thymosin Alpha-1 has shown promise for reducing mortality by helping restore immune balance. It's particularly interesting because it modulates immunity rather than just boosting it—calming overreaction while enhancing pathogen-fighting ability.
Thymulin (FTS)
- Age-Related Immune Decline
- Thymulin levels naturally drop significantly in elderly populations. [9][10] Supplementation can restore T cell maturation and immune responsiveness in aging. [23] Research shows thymulin can reverse age-related thymic involution and restore helper/suppressor T cell balance. [7][11]
- Recovery from Severe Malnutrition
- In severely malnourished individuals, the thymus shrinks and T cell development is impaired. [24] In vitro studies show thymulin can restore T cell maturation even in those with thymic involution, [13] making it useful in recovery protocols.
- Chronic Inflammatory Conditions
- Thymulin inhibits NF-κB activation and suppresses pro-inflammatory cytokines (IL-6, TNF-α, IL-8). [14][16] Animal models show effectiveness in lung diseases, inflammatory pain, and neuroinflammation. [14][15][17] Anti-inflammatory effects work through p38 MAPK suppression. [15]
Safety profile
Side effects
Thymosin Alpha-1
Common
- Injection site reactions
Uncommon
- Mild fatigue
- Flu-like symptoms
- Mild fever
- Lymph node awareness
Serious
- Allergic reaction
Thymulin (FTS)
Common
- Local injection site reactions
- Mild fatigue or lethargy
- Transient headache
Uncommon
- Mild fever or chills
- Sleep disturbance or vivid dreams
- Appetite changes
- Transient lymph node swelling
Serious
- Severe allergic reaction
- Uncontrolled immune activation
Research status
Safety & evidence
Thymosin Alpha-1
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Not FDA approved. There is no thymalfasin application in Drugs@FDA. It is used outside the US (as Zadaxin) for chronic hepatitis B and as an immune adjuvant.
- Safety overview
- Thymosin Alpha-1 has one of the most extensive safety records of any peptide, with decades of clinical use across multiple countries. Studies consistently report minimal side effects—mostly limited to mild injection site reactions. The 2-hour half-life means it doesn't accumulate in your system. It's been used safely in thousands of patients with hepatitis, cancer, and other serious conditions.
Contraindications
- Organ transplant recipients on immunosuppressants
- Active autoimmune disease flares
- Known allergy to thymosin peptides
- Pregnancy or breastfeeding
- Children under 18 without medical supervision
Thymulin (FTS)
- Evidence level
- Limited human trials
- FDA status
- Research compound
- Safety overview
- Thymulin is a naturally occurring thymic hormone with favorable safety profile in research. No reported serious adverse events in animal models even at high doses. [8][14] Limited human safety data but observed studies suggest good tolerability. Requires concurrent zinc supplementation for biological activity [6][7] and additional safety assurance. Most concerns relate to immune overactivation in susceptible individuals, not direct peptide toxicity.
Contraindications
- Uncontrolled autoimmune disease
- Severe zinc deficiency requiring IV repletion
- Thymic tumors or malignancies
- Pregnancy (limited safety data)
Decision guide
Which is right for you?
Thymosin Alpha-1
Choose Thymosin Alpha-1 if…
- Immune system strengthening
- Chronic infection support
- Cancer adjunct therapy
- Healthy aging immune support
Thymulin (FTS)
Choose Thymulin (FTS) if…
- Immune system restoration
- T cell maturation in immunocompromised states
- Age-related immune decline
- Chronic inflammatory conditions